Compare VOYA & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOYA | TFX |
|---|---|---|
| Founded | 1975 | 1943 |
| Country | United States | United States |
| Employees | 11000 | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 5.3B |
| IPO Year | N/A | 1994 |
| Metric | VOYA | TFX |
|---|---|---|
| Price | $82.55 | $125.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $84.90 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.1M | 697.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $3.13 | $15.97 |
| Revenue Next Year | $3.93 | $5.15 |
| P/E Ratio | $12.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $64.50 | $100.18 |
| 52 Week High | $84.00 | $139.67 |
| Indicator | VOYA | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 43.81 |
| Support Level | $72.94 | $123.80 |
| Resistance Level | $84.00 | $130.56 |
| Average True Range (ATR) | 1.78 | 3.57 |
| MACD | -0.28 | -0.92 |
| Stochastic Oscillator | 97.11 | 10.45 |
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.